NCT04058704View on ClinicalTrials.gov

A Study to Determine the Efficiency For Brain Metastasis NSCLC Patients Treated With Icotinib Alone or Combined With Radiation Therapy

PHASE3UnknownINTERVENTIONAL
Enrollment

296

Participants

Timeline

Start Date

July 20, 2018

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2022

Conditions
Non Small Cell Lung CancerBrain Metastases
Interventions
DRUG

Icotinib

125mg Tid/375mg per day

RADIATION

SRS/WBRT/HA-WBRT/SMART

\>3 with WBRT/HA-WBRT/SMART or 1-3 with SRS

Trial Locations (1)

Unknown

RECRUITING

Zhejiang Cancer Hospital, Hangzhou

Sponsors
All Listed Sponsors
lead

Betta Pharmaceuticals Co., Ltd.

INDUSTRY